07 July 2026 - ASX-listed Identitii (ID8) announced a significant financing agreement, including an initial $5 million binding commitment contingent on shareholder approval, to fund BNDRY and global marketing.
07 July 2026 - The capital raise, following positive early clinical data, will fund the lead asset through key milestones and extend operations into 2027.
0 min
About Latest Company News - Finance News Network
From the publisher's feed
The latest Company News from Finance News Network.